Positive airway pressure (PAP) devices are used to treat patients with sleep related
breathing disorders (SRBD) including obstructive sleep apnea (OSA). Currently, PAP …

Rationale: Continuous positive airway pressure (CPAP) is the current treatment for patients
with symptomatic obstructive sleep apnea (OSA). Its use for all subjects with sleep …

Positive airway pressure (PAP) is used to treat obstructive sleep apnea (OSA), central sleep
apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis …

Obstructive sleep apnea (OSA) is characterised by repetitive cessation or reduction of
airflow due to upper airway obstructions. These respiratory events lead to chronic sleep …

Obstructive sleep apnoea-hypopnoea (OSAH) causes excessive daytime sleepiness,
impairs quality-of-life, and increases cardiovascular disease and road traffic accident risks …

Background: Continuous positive airway pressure (CPAP) is considered the treatment of
choice for obstructive sleep apnea (OSA), and studies have shown that there is a correlation …

Importance Obstructive sleep apnea (OSA) is associated with adverse health outcomes.
Objective To review the evidence on screening for OSA in asymptomatic adults or those with …

Background Although continuous positive airway pressure (CPAP) has become the
standard of care in the treatment of obstructive sleep apnea (OSA), 2 systematic reviews …

Obesity is the most powerful risk factor for obstructive sleep apnea (OSA), and it is
essentially the only reversible one. OSA and obesity share common substrates, pathologic …

Study objectives The aims of this study were to analyze mortality in patients with obstructive
sleep apnea-hypopnea syndrome (OSAHS) treated with positive airway pressure (PAP) and …